“schizophrenia” Archives

in
Entry Author Date Location
Bio Roundup: NIH Precision Boost, AHCA to Senate, New Drugs & More 05/05/17 National
FDA Wants More Safety Info on Psych Drug, Intra-Cellular Shares Drop 05/01/17 New York
Biotech Vet Dunsire’s New Challenge: Grow Tiny Startup, XTuit 03/08/17 Boston
BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders 10/20/16 San Francisco
Promentis, Kiio, EmOpti, & More: This Week’s Wisconsin Watchlist 10/12/16 Wisconsin
Intra-Cellular Shares Sink As Schizophrenia Drug Flunks Final Test 09/28/16 New York
Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More 09/02/16 National
After Failed Schizophrenia Trial, Forum Pharma To Shutter This Week 06/27/16 Boston
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
Minerva’s Shares Soar on Early Data for Schizophrenia Drug 05/26/16 Boston
After Failed Trial, Forum CEO Dunsire Leaves, Company’s Fate Unclear 05/25/16 Boston
East Coast Biotech Roundup: NY Disruptors, Commense, Regeneron, & More 04/01/16 Boston
Restructuring Looms for Forum as Neuro Drug Fails Key Clinical Test 03/24/16 Boston
NY Stem Cell Foundation Grows, Eyes Forming Big Apple Bio Incubator 12/03/15 New York
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
Dunsire, Forum Search For Answers After FDA Halts Alzheimer’s Trial 09/29/15 Boston
East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More 09/21/15 Boston
Intra-Cellular Surges as Schizophrenia Drug Passes First Key Test 09/16/15 New York
“RoboRoach” Startup Hopes Partners, TED Talk Help Usher In Profits 05/11/15 Detroit Ann Arbor
Dunsire, Forum Pharma Look Beyond Fidelity For Big Alzheimer’s Push 04/22/15 Boston
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More 04/13/15 Boston
East Coast Biotech Roundup: Pre-J.P. Morgan Preening Edition 01/09/15 Boston
Tetra Discovery Lands Funding, Plans Alzheimer’s Drug Trial in 2015 10/31/14 Detroit Ann Arbor
Invest Michigan Awards $275K to Four Early-Stage Tech Startups 10/28/14 Detroit Ann Arbor
Stanley Gives Broad Institute $650M Gift For Psych Research 07/22/14 Boston
Alkermes Scores Phase 3 Win for Long-Lasting Schizophrenia Drug 04/08/14 Boston
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
Retrophin Shares Boom Following Manchester Pharma Buyout 02/13/14 New York
Promentis’s $2.9M Series B Round to Fund Human Trials 01/16/14 Wisconsin
Alkermes Nabs $250M It Doesn’t Need, But Could Fend Off Barbarians 01/13/14 Boston
Page 1 of 3 next page »